The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year strategic research collaboration agreement to evaluate zanidatamab, Jazz’s investigational HER2-targeted bispecific antibody, in multiple HER2-expressing cancers.
Study reveals how a person remembers experiences of childhood abuse or neglect can impact future emotional disorders
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and City University New York, published today (Wednesday 5 July)